Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Peritoneal Cancer × Clear all

Status

Completed 2 Unknown 1 Terminated 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 1550 Neoplasms 1045 Colorectal Neoplasms 881 Carcinoma, Non-Small-Cell Lung 856 Stomach Neoplasms 685 Carcinoma, Hepatocellular 676 Lung Neoplasms 633 Prostatic Neoplasms 583 Pancreatic Neoplasms 480 Rectal Neoplasms 364 Neoplasm Metastasis 351 Ovarian Neoplasms 343 Colonic Neoplasms 338 Uterine Cervical Neoplasms 327 Recurrence 326 Leukemia, Myeloid, Acute 321 Esophageal Neoplasms 291 Multiple Myeloma 286 Lymphoma 277 Head and Neck Neoplasms 277 Melanoma 266 Brain Neoplasms 230 Precursor Cell Lymphoblastic Leukemia-Lymphoma 229 Urinary Bladder Neoplasms 218 Lymphoma, Large B-Cell, Diffuse 192 Nasopharyngeal Carcinoma 191 Leukemia 189 Liver Neoplasms 180 Squamous Cell Carcinoma of Head and Neck 169 Glioblastoma 169

Interventions

Oxaliplatin 1 Hyperthermic Intraperitoneal Chemotherapy 1 Cytoreduction Surgical Procedures 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04122885 2019-10-10

IMMUNOPAC

University Hospital Tuebingen

Peritoneal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡